As I thought, Cephalon will lead the approval process with FDA...

As I thought, Cephalon will lead the approval process with FDA should the trial data come up ok by end of Mar. They have extensive experience with dealing with FDA, something that was sadly lacking with CXS.

Here's an extract from the article...

The company could be in a position to seek approval for Omapro, for which Cephalon has an agreement with ChemGenex Pharmaceuticals, later this year. Omapro is being developed for the treatment of chronic myelogenous leukemia.

http://www.zacks.com/stock/news/47481/Cephalon+Beats%3B+Ups+View